Radislav Sedlacek

995 total citations
20 papers, 713 citations indexed

About

Radislav Sedlacek is a scholar working on Cancer Research, Oncology and Hematology. According to data from OpenAlex, Radislav Sedlacek has authored 20 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cancer Research, 14 papers in Oncology and 8 papers in Hematology. Recurrent topics in Radislav Sedlacek's work include Protease and Inhibitor Mechanisms (19 papers), Peptidase Inhibition and Analysis (14 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Radislav Sedlacek is often cited by papers focused on Protease and Inhibitor Mechanisms (19 papers), Peptidase Inhibition and Analysis (14 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Radislav Sedlacek collaborates with scholars based in Germany, Switzerland and Czechia. Radislav Sedlacek's co-authors include Thorsten Sadowski, Sebastian Dietrich, Cornelia Kolb, Ulrich Krawinkel, Valentin Djonov, Markus S. Mueller, Rena Brauer, Bjoern Titz, Rolf Mentlein and E. Proksch and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and International Journal of Cancer.

In The Last Decade

Radislav Sedlacek

19 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Radislav Sedlacek Germany 15 480 329 268 146 115 20 713
Sonia Hernandez‐Barrantes United States 6 587 1.2× 387 1.2× 237 0.9× 238 1.6× 157 1.4× 6 781
Leslie Nehring United States 6 493 1.0× 300 0.9× 307 1.1× 164 1.1× 155 1.3× 12 800
Hidehiro Nomura Japan 8 408 0.8× 327 1.0× 146 0.5× 134 0.9× 113 1.0× 13 548
Yiliang E. Liu United States 10 646 1.3× 429 1.3× 343 1.3× 260 1.8× 89 0.8× 11 976
Rosemarie Chirco United States 4 320 0.7× 237 0.7× 310 1.2× 90 0.6× 117 1.0× 4 662
Marc A. Lafleur Australia 15 461 1.0× 314 1.0× 400 1.5× 209 1.4× 221 1.9× 20 921
Hidetoshi Matsuda Japan 5 324 0.7× 245 0.7× 182 0.7× 93 0.6× 99 0.9× 5 584
Cynthia E. Wilkins-Port United States 14 250 0.5× 162 0.5× 245 0.9× 66 0.5× 121 1.1× 17 588
Samantha A. Oblander United States 7 285 0.6× 208 0.6× 276 1.0× 87 0.6× 90 0.8× 8 679

Countries citing papers authored by Radislav Sedlacek

Since Specialization
Citations

This map shows the geographic impact of Radislav Sedlacek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radislav Sedlacek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radislav Sedlacek more than expected).

Fields of papers citing papers by Radislav Sedlacek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radislav Sedlacek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radislav Sedlacek. The network helps show where Radislav Sedlacek may publish in the future.

Co-authorship network of co-authors of Radislav Sedlacek

This figure shows the co-authorship network connecting the top 25 collaborators of Radislav Sedlacek. A scholar is included among the top collaborators of Radislav Sedlacek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radislav Sedlacek. Radislav Sedlacek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dvořák, Michal, Jiřı́ Salát, Andrea Fořtová, et al.. (2025). Sex-dependent impairment of antibody responses to tick-borne encephalitis virus vaccination and infection in obese mice. Journal of General Virology. 106(10).
2.
Brauer, Rena, et al.. (2011). Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen. BMC Biochemistry. 12(1). 38–38. 25 indexed citations
3.
Müller, Matthias, Annette Paschen, E. Proksch, et al.. (2010). MMP19 is upregulated during melanoma progression and increases invasion of melanoma cells. Modern Pathology. 23(4). 511–521. 41 indexed citations
4.
Hattermann, Kirsten, et al.. (2010). Matrix Metalloproteinase-19 is Highly Expressed in Astroglial Tumors and Promotes Invasion of Glioma Cells. Journal of Neuropathology & Experimental Neurology. 69(3). 215–223. 36 indexed citations
5.
Ko, Josephine Mun Yee, Hong Lok Lung, Radislav Sedlacek, et al.. (2010). Catalytic activity of matrix metalloproteinase‐19 is essential for tumor suppressor and anti‐angiogenic activities in nasopharyngeal carcinoma. International Journal of Cancer. 129(8). 1826–1837. 46 indexed citations
6.
Rückert, René, Katja Brandt, Markus S. Mueller, et al.. (2008). MMP19 Is Essential for T Cell Development and T Cell-Mediated Cutaneous Immune Responses. PLoS ONE. 3(6). e2343–e2343. 50 indexed citations
7.
Aebersold, Daniel M., et al.. (2007). Matrix metalloproteinase-19 is a predictive marker for tumor invasiveness in patients with oropharyngeal squamous cell carcinoma. The International Journal of Biological Markers. 22(4). 265–273. 13 indexed citations
8.
Aebersold, Daniel M., et al.. (2007). Matrix Metalloproteinase-19 is a Predictive Marker for Tumor Invasiveness in Patients with Oropharyngeal Squamous Cell Carcinoma. The International Journal of Biological Markers. 22(4). 265–273. 9 indexed citations
9.
Müller, Matthias, Rolf Mentlein, Thorsten Sadowski, et al.. (2006). Matrix Metalloproteinase-19 Expression in Keratinocytes Is Repressed by Transcription Factors Tst-1 and Skn-1a: Implications for Keratinocyte Differentiation. Journal of Investigative Dermatology. 127(5). 1107–1114. 18 indexed citations
10.
Dingley, Andrew J., et al.. (2005). Structural characterization and binding properties of the hemopexin-like domain of the matrixmetalloproteinase-19. Protein Expression and Purification. 46(2). 406–413. 10 indexed citations
11.
Sadowski, Thorsten, Sebastian Dietrich, Andreas Ludwig, et al.. (2005). Matrix metalloproteinase 19 processes the laminin 5 gamma 2 chain and induces epithelial cell migration. Cellular and Molecular Life Sciences. 62(7-8). 870–880. 62 indexed citations
12.
Titz, Bjoern, Sebastian Dietrich, Thorsten Sadowski, et al.. (2004). Activity of MMP-19 inhibits capillary-like formation due to processing of nidogen-1. Cellular and Molecular Life Sciences. 61(14). 1826–33. 34 indexed citations
13.
Sadowski, Thorsten, Sebastian Dietrich, Matthias Müller, et al.. (2003). Matrix Metalloproteinase-19 Expression in Normal and Diseased Skin: Dysregulation by Epidermal Proliferation. Journal of Investigative Dermatology. 121(5). 989–996. 41 indexed citations
15.
Kolb, Cornelia, et al.. (2002). Matrix Metalloproteinase-19 Is Expressed in Myeloid Cells in an Adhesion-Dependent Manner and Associates with the Cell Surface. The Journal of Immunology. 168(3). 1244–1251. 45 indexed citations
16.
Djonov, Valentin, et al.. (2001). MMP-19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours. The Journal of Pathology. 195(2). 147–155. 57 indexed citations
17.
Mueller, Markus S., et al.. (2000). Structure of the human MMP-19 gene. Gene. 252(1-2). 27–37. 26 indexed citations
18.
Mueller, Markus S., et al.. (2000). The murine ortholog of matrix metalloproteinase 19: its cloning, gene organization, and expression. Gene. 256(1-2). 101–111. 14 indexed citations
19.
Kolb, Cornelia, et al.. (1999). Matrix Metalloproteinase-19 in Capillary Endothelial Cells: Expression in Acutely, but Not in Chronically, Inflamed Synovium. Experimental Cell Research. 250(1). 122–130. 42 indexed citations
20.
Kolb, Cornelia, et al.. (1997). The matrix metalloproteinase RASI-1 is expressed in synovial blood vessels of a rheumatoid arthritis patient. Immunology Letters. 57(1-3). 83–88. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026